|
Market Cap (24-Jun) $4,932,594,176 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (26-May) 50,730,266 (14.95%) (3rd) |
|
52w High $25.87 |
52w Low $8.26 |
P/E 2,000.00 |
EPS -0.03 |
A news article has been posted about Telix Pharmaceuticals on the AFR. The article was published around , on 5 January 2024 at 10:20am.
Australian shares shrug off Wall Street losses to open higher. Telix Pharmaceuticals mulls Nasdaq listing. BlueBet jumps on merger talks. Follow updates here.
Read ArticleTLX was $11.22 at the close of trade on 30 June 2023
| Recent Articles about ASX:TLX | |
|---|---|
| 16-Jun | Appendix 3Y Change in Director Interest - C Behrenbruch
company-announcements.afr.com |
| 16-Jun | Appendix 3Y Change in Director Interest - Maria Rivas - 01 Jun 2026
company-announcements.afr.com |
| 16-Jun | Becoming a substantial holder - ASX Announcement - Market Index
company-announcements.afr.com |
| 12-Jun | Dr Rosalind Wilson appointed as Chief Medical Officer - AFR
company-announcements.afr.com |
| 22-May | Telix Annual General Meeting Chairman and CEO Addresses
company-announcements.afr.com |
| 22-May | Telix Results of Annual General Meeting
company-announcements.afr.com |
| 21-May | Notice of change of interests of substantial holder
company-announcements.afr.com |
| 21-May | Appendix 3X - Initial Director's Interest Notice - AFR
company-announcements.afr.com |
| 4-May | cyclopharm - AFR
company-announcements.afr.com |
| 4-May | Telix Successfully Prices and Upsizes US$600 Million Convertible ...
company-announcements.afr.com |
| Tracked |
Find all articles about Telix Pharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.
Telix Pharmaceuticals 